![The super elongation complex drives transcriptional addiction in MYCN- amplified neuroblastoma | Science Advances The super elongation complex drives transcriptional addiction in MYCN- amplified neuroblastoma | Science Advances](https://www.science.org/cms/10.1126/sciadv.adf0005/asset/6d6c19a9-79d4-4fa5-b368-b1878533f38b/assets/images/large/sciadv.adf0005-f7.jpg)
The super elongation complex drives transcriptional addiction in MYCN- amplified neuroblastoma | Science Advances
![Implementation of Novel Mode for Evaluation of MYCN Amplification that can Predict Outcome in Patients with Neuroblastoma | Clinical Oncology and Research | Science Repository | Open Access Implementation of Novel Mode for Evaluation of MYCN Amplification that can Predict Outcome in Patients with Neuroblastoma | Clinical Oncology and Research | Science Repository | Open Access](https://www.sciencerepository.org/articles/figures/COR-2020-11-104_3.png)
Implementation of Novel Mode for Evaluation of MYCN Amplification that can Predict Outcome in Patients with Neuroblastoma | Clinical Oncology and Research | Science Repository | Open Access
![The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development | SpringerLink The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00595-019-01790-0/MediaObjects/595_2019_1790_Fig1_HTML.png)
The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development | SpringerLink
![Cancers | Free Full-Text | Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma Cancers | Free Full-Text | Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma](https://pub.mdpi-res.com/cancers/cancers-14-02627/article_deploy/html/images/cancers-14-02627-ag.png?1653536441)
Cancers | Free Full-Text | Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma
![A new approach to predict the presence of MYCN gene amplification in pediatric brain tumors by analyzing RNA molecules | ASPIC A new approach to predict the presence of MYCN gene amplification in pediatric brain tumors by analyzing RNA molecules | ASPIC](https://www.aspic.pt/sites/default/files/field/image/Moreno.jpg)
A new approach to predict the presence of MYCN gene amplification in pediatric brain tumors by analyzing RNA molecules | ASPIC
![Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation](https://www.thno.org/v10/p6411/toc.jpg)
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
![Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells: Molecular Therapy - Nucleic Acids Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/bd8fa2c7-832e-4086-81cb-570c4e11c9ff/fx1_lrg.jpg)
Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells: Molecular Therapy - Nucleic Acids
![MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma | Journal of Clinical Pathology MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/76/9/599/F1.large.jpg)
MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma | Journal of Clinical Pathology
![MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent | Cell Death & Disease MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-018-0295-5/MediaObjects/41419_2018_295_Fig1_HTML.jpg)
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent | Cell Death & Disease
![IJMS | Free Full-Text | Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs IJMS | Free Full-Text | Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs](https://www.mdpi.com/ijms/ijms-22-12883/article_deploy/html/images/ijms-22-12883-g001.png)
IJMS | Free Full-Text | Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs
![The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells - eBioMedicine The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells - eBioMedicine](https://www.thelancet.com/cms/asset/89c0e751-d84f-4678-b450-9d2203754ffd/gr1.jpg)
The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells - eBioMedicine
![Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification | PNAS Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification | PNAS](https://www.pnas.org/cms/10.1073/pnas.1208215109/asset/08f51e1a-10e7-4cc0-9c45-45cd64a0f594/assets/graphic/pnas.1208215109fig01.jpeg)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification | PNAS
![MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma | Cancer Cell International | Full Text MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-017-0412-z/MediaObjects/12935_2017_412_Fig2_HTML.gif)